高级检索
当前位置: 首页 > 详情页

Circ_cse1l Inhibits Colorectal Cancer Proliferation by Binding to eIF4A3

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Affiliated Hosp 4, Dept Gen Surg, Shijiazhuang, Hebei, Peoples R China [2]Hebei Med Univ, Basic Med Coll, Dept Biochem & Mol Biol, Shijiazhuang, Hebei, Peoples R China
出处:
ISSN:

关键词: Biological Markers Cell Proliferation Colorectal Neoplasms Diagnosis DNA Circular Eukaryotic Initiation Factor-4A

摘要:
Background: Circular RNAs (circRNAs) are involved in the growth of many tumors. However, the expression and possible role of circ_cse1l (hsa_circ_0060745) in colorectal cancer (CRC) are unclear. The present study was designed to explore the role of circ_cse1l in CRC. Material/Methods: The levels of circ_cse1l expression in cancer tissues and serum samples of 50 patients with CRC and in con trol subjects were analyzed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). CCK-8, colony formation, transwell and wound healing assays were performed to assess the functions of circ_cse1l in CRC cell lines after overexpression. The relationship between circ_cse1l and eIF4A3 during cell proliferation was analyzed by western blotting and RNA-binding protein immunoprecipitation (RIP). Results: qRT-PCR assays showed that the levels of expression of circ_cse1l were lower in CRC cell lines and in tissue and serum samples from patients with CRC than in control samples. The expression of circ_cse1l in CRC tissues had clinical significance, as its level of expression was inversely associated with the depth of tumor invasion. Overexpression of circ_cse1l in HT29 and HCT116 cells markedly reduced cell proliferation and metastasis. Western blotting showed that circ_cse1l overexpression dowregulated the expression of PCNA protein. RIP results demonstrated that circ_cse1l inhibited the proliferation of CRC cells by binding to eIF4A3. Conclusions: The expression of circ_cse1l is downregulated in CRC Furthermore, circ_cse1l downregulated PCNA expression by binding to eIF4A3, inhibiting the proliferation of CRC cells.

基金:

基金编号: H2019206028

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
JCR分区:
出版当年[2020]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Affiliated Hosp 4, Dept Gen Surg, Shijiazhuang, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Med Univ, Affiliated Hosp 4, Dept Gen Surg, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39767 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号